[
  {
    "ts": "2025-11-26T01:52:57+00:00",
    "headline": "Trump administration slashes Ozempic and Wegovy price for Medicare",
    "summary": "The US government has negotiated a 71 per cent discount for Novo Nordisk’s weight-loss drugs Ozempic and Wegovy for patients enrolled in Medicare...",
    "url": "https://finance.yahoo.com/news/trump-administration-slashes-ozempic-wegovy-015257263.html",
    "source": "Financial Times",
    "provider": "yfinance",
    "raw": {
      "id": "40d79c9f-00e1-3ebf-a1af-7058a1562a2c",
      "content": {
        "id": "40d79c9f-00e1-3ebf-a1af-7058a1562a2c",
        "contentType": "STORY",
        "title": "Trump administration slashes Ozempic and Wegovy price for Medicare",
        "description": "",
        "summary": "The US government has negotiated a 71 per cent discount for Novo Nordisk’s weight-loss drugs Ozempic and Wegovy for patients enrolled in Medicare...",
        "pubDate": "2025-11-26T01:52:57Z",
        "displayTime": "2025-11-26T01:52:57Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2025-11/ecd6aca0-ca7d-11f0-bbdf-308e30c26b49",
          "originalWidth": 5800,
          "originalHeight": 3856,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5GN.xl0yoOZ9rASn727bRg--~B/aD0zODU2O3c9NTgwMDthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2025-11/ecd6aca0-ca7d-11f0-bbdf-308e30c26b49.cf.webp",
              "width": 5800,
              "height": 3856,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_Ur0b.rYqO.iixKcxBvlnw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2025-11/ecd6aca0-ca7d-11f0-bbdf-308e30c26b49.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Financial Times",
          "url": "https://www.ft.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/trump-administration-slashes-ozempic-wegovy-015257263.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/trump-administration-slashes-ozempic-wegovy-015257263.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVO"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-26T06:08:31+00:00",
    "headline": "JPMorgan Raises Eli Lilly (LLY) Price Target to $1,150, Maintains Overweight Rating",
    "summary": "Eli Lilly and Company (NYSE:LLY) is included among the 15 Best Stocks to Buy for Medium Term. On‍ November 18, JPMorgan analyst Chris Scho‍tt r‌aised the firm‍’s‍ price ta‌rg​et on Eli Lilly and Company (NYSE:LLY) to $1,150 from $1,050 wh‍ile maintaining an Overw‍eig​ht ratin⁠g after meetings with management. JPMorgan said the di‌scu‌ss⁠ions‌ re‌inforced its positive […]",
    "url": "https://finance.yahoo.com/news/jpmorgan-raises-eli-lilly-lly-060831576.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "61674905-f2f8-3d11-934b-57c04205981e",
      "content": {
        "id": "61674905-f2f8-3d11-934b-57c04205981e",
        "contentType": "STORY",
        "title": "JPMorgan Raises Eli Lilly (LLY) Price Target to $1,150, Maintains Overweight Rating",
        "description": "",
        "summary": "Eli Lilly and Company (NYSE:LLY) is included among the 15 Best Stocks to Buy for Medium Term. On‍ November 18, JPMorgan analyst Chris Scho‍tt r‌aised the firm‍’s‍ price ta‌rg​et on Eli Lilly and Company (NYSE:LLY) to $1,150 from $1,050 wh‍ile maintaining an Overw‍eig​ht ratin⁠g after meetings with management. JPMorgan said the di‌scu‌ss⁠ions‌ re‌inforced its positive […]",
        "pubDate": "2025-11-26T06:08:31Z",
        "displayTime": "2025-11-26T06:08:31Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/30173640c9b0cffb6b7013930030fa3e",
          "originalWidth": 1920,
          "originalHeight": 1275,
          "caption": "JPMorgan Raises Eli Lilly (LLY) Price Target to $1,150, Maintains Overweight Rating",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TkRKqkPAOo0eEJXaJY9Y2A--~B/aD0xMjc1O3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/30173640c9b0cffb6b7013930030fa3e.cf.webp",
              "width": 1920,
              "height": 1275,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pTG9ApYeTSmSfYp_rFmJ.g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/30173640c9b0cffb6b7013930030fa3e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jpmorgan-raises-eli-lilly-lly-060831576.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jpmorgan-raises-eli-lilly-lly-060831576.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-26T09:15:00+00:00",
    "headline": "Did Pfizer Just Say \"Checkmate\" to Novo Nordisk?",
    "summary": "The weight loss drug market may approach almost $100 billion by the end of the decade.",
    "url": "https://www.fool.com/investing/2025/11/26/did-pfizer-just-say-checkmate-to-novo-nordisk/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "a9c76fd0-7f7e-3291-8da7-35ab07377880",
      "content": {
        "id": "a9c76fd0-7f7e-3291-8da7-35ab07377880",
        "contentType": "STORY",
        "title": "Did Pfizer Just Say \"Checkmate\" to Novo Nordisk?",
        "description": "",
        "summary": "The weight loss drug market may approach almost $100 billion by the end of the decade.",
        "pubDate": "2025-11-26T09:15:00Z",
        "displayTime": "2025-11-26T09:15:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/4fcfd60229c3102295f150f35c7f44a9",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "An investor works on a laptop at home.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/d5go1zahkMsoTLoejEiWtQ--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/4fcfd60229c3102295f150f35c7f44a9.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/uPTcf6UgoVqg6lmpUaUE7g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/4fcfd60229c3102295f150f35c7f44a9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/11/26/did-pfizer-just-say-checkmate-to-novo-nordisk/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/did-pfizer-just-checkmate-novo-091500358.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-26T12:30:00+00:00",
    "headline": "BMO Launches New CDRs With Exposure to U.S. Stocks Including Microsoft, Eli Lilly, Exxon, Chevron and Robinhood",
    "summary": "Bank of Montreal (BMO) announced five new Canadian depositary receipts (CDRs) will begin trading on the Cboe Canada exchange today. The initial offering of these new CDRs has closed.",
    "url": "https://finance.yahoo.com/news/bmo-launches-cdrs-exposure-u-123000173.html",
    "source": "CNW Group",
    "provider": "yfinance",
    "raw": {
      "id": "439a83c3-6fe5-3d4e-bbec-9f93d5d33486",
      "content": {
        "id": "439a83c3-6fe5-3d4e-bbec-9f93d5d33486",
        "contentType": "STORY",
        "title": "BMO Launches New CDRs With Exposure to U.S. Stocks Including Microsoft, Eli Lilly, Exxon, Chevron and Robinhood",
        "description": "",
        "summary": "Bank of Montreal (BMO) announced five new Canadian depositary receipts (CDRs) will begin trading on the Cboe Canada exchange today. The initial offering of these new CDRs has closed.",
        "pubDate": "2025-11-26T12:30:00Z",
        "displayTime": "2025-11-26T12:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/cnwgroup.com/caf0230d3d561e2d8229af763199790b",
          "originalWidth": 16,
          "originalHeight": 16,
          "caption": "Cision",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/2jKNmMP8xx5D3BOYyRBXzA--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/cnwgroup.com/caf0230d3d561e2d8229af763199790b.cf.webp",
              "width": 16,
              "height": 16,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/y2tJ7.IDnkf5oHxlmy5FLg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/cnwgroup.com/caf0230d3d561e2d8229af763199790b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "CNW Group",
          "url": "http://www.newswire.ca/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bmo-launches-cdrs-exposure-u-123000173.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bmo-launches-cdrs-exposure-u-123000173.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMO"
            },
            {
              "symbol": "HOOD"
            },
            {
              "symbol": "MSFT"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "XOM"
            },
            {
              "symbol": "CVX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-26T11:29:53+00:00",
    "headline": "Jim Cramer Discusses Eli Lilly (LLY) Touching the Trillion Dollar Market Value",
    "summary": "We recently published 11 Stocks Jim Cramer Shared His Insights On. Eli Lilly and Company (NYSE:LLY) is one of the stocks Jim Cramer discussed. Eli Lilly and Company (NYSE:LLY) is one of Cramer’s top stocks in the pharmaceutical space. He has remained optimistic about the firm throughout the year and praised its lead in the weight […]",
    "url": "https://finance.yahoo.com/news/jim-cramer-discusses-eli-lilly-112953138.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "48e2103f-8707-30fc-a2c9-476216ad949b",
      "content": {
        "id": "48e2103f-8707-30fc-a2c9-476216ad949b",
        "contentType": "STORY",
        "title": "Jim Cramer Discusses Eli Lilly (LLY) Touching the Trillion Dollar Market Value",
        "description": "",
        "summary": "We recently published 11 Stocks Jim Cramer Shared His Insights On. Eli Lilly and Company (NYSE:LLY) is one of the stocks Jim Cramer discussed. Eli Lilly and Company (NYSE:LLY) is one of Cramer’s top stocks in the pharmaceutical space. He has remained optimistic about the firm throughout the year and praised its lead in the weight […]",
        "pubDate": "2025-11-26T11:29:53Z",
        "displayTime": "2025-11-26T11:29:53Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/7746a495763c517cd6ea96985a667439",
          "originalWidth": 1920,
          "originalHeight": 1280,
          "caption": "Jim Cramer Discusses Eli Lilly (LLY) Touching the Trillion Dollar Market Value ",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/L.y5eHntIJd0XzA2FsxbTA--~B/aD0xMjgwO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/7746a495763c517cd6ea96985a667439.cf.webp",
              "width": 1920,
              "height": 1280,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6ji6jibByYrwJ8.gSBa.ig--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/7746a495763c517cd6ea96985a667439.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-discusses-eli-lilly-112953138.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-discusses-eli-lilly-112953138.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-26T11:13:29+00:00",
    "headline": "Novo Nordisk Faces 71% Medicare Price Cuts on Ozempic and Wegovy",
    "summary": "U.S. government move slashes costs for key diabetes and weight-loss drugs beginning in 2027.",
    "url": "https://finance.yahoo.com/news/novo-nordisk-faces-71-medicare-111329584.html",
    "source": "GuruFocus.com",
    "provider": "yfinance",
    "raw": {
      "id": "c2fca1c4-d638-3930-9b94-ca792467197d",
      "content": {
        "id": "c2fca1c4-d638-3930-9b94-ca792467197d",
        "contentType": "STORY",
        "title": "Novo Nordisk Faces 71% Medicare Price Cuts on Ozempic and Wegovy",
        "description": "",
        "summary": "U.S. government move slashes costs for key diabetes and weight-loss drugs beginning in 2027.",
        "pubDate": "2025-11-26T11:13:29Z",
        "displayTime": "2025-11-26T11:13:29Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/us.finance.gurufocus/607644c1b912fd342c4a01abf25ed2ac",
          "originalWidth": 4800,
          "originalHeight": 3200,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/dJZiq6ZXT1lPk38oaPwUng--~B/aD0zMjAwO3c9NDgwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/us.finance.gurufocus/607644c1b912fd342c4a01abf25ed2ac.cf.webp",
              "width": 4800,
              "height": 3200,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/R2ZHBTsTFBdZ50fR91UiNQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/607644c1b912fd342c4a01abf25ed2ac.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GuruFocus.com",
          "url": "http://www.gurufocus.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/novo-nordisk-faces-71-medicare-111329584.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/novo-nordisk-faces-71-medicare-111329584.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVO"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-26T10:30:00+00:00",
    "headline": "Hedge Funds Pile Into Health Stocks Leading Market in Rotation",
    "summary": "The S&P 500 Health Care Index is up 10% through Tuesday, outperforming the other 10 sectors in the benchmark for US stocks.  Eli Lilly & Co. has surged 29% to become the first health company with a $1 trillion valuation.  Regeneron Pharmaceuticals Inc., Merck & Co. and Biogen Inc. are all up at least 18% since the end of October.",
    "url": "https://finance.yahoo.com/news/hedge-funds-pile-health-stocks-103000490.html",
    "source": "Bloomberg",
    "provider": "yfinance",
    "raw": {
      "id": "7dbe69ea-dd94-364c-a276-2d9575e99343",
      "content": {
        "id": "7dbe69ea-dd94-364c-a276-2d9575e99343",
        "contentType": "STORY",
        "title": "Hedge Funds Pile Into Health Stocks Leading Market in Rotation",
        "description": "",
        "summary": "The S&P 500 Health Care Index is up 10% through Tuesday, outperforming the other 10 sectors in the benchmark for US stocks.  Eli Lilly & Co. has surged 29% to become the first health company with a $1 trillion valuation.  Regeneron Pharmaceuticals Inc., Merck & Co. and Biogen Inc. are all up at least 18% since the end of October.",
        "pubDate": "2025-11-26T10:30:00Z",
        "displayTime": "2025-11-26T10:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/bloomberg_holding_pen_162/8068ea9d99335c06f0c58782f8710c9f",
          "originalWidth": 1184,
          "originalHeight": 916,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/f_wrvinIvmc3q3FP.MRVtg--~B/aD05MTY7dz0xMTg0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/bloomberg_holding_pen_162/8068ea9d99335c06f0c58782f8710c9f.cf.webp",
              "width": 1184,
              "height": 916,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/geW_v7AG95GwdDDQc37Bgg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/bloomberg_holding_pen_162/8068ea9d99335c06f0c58782f8710c9f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Bloomberg",
          "url": "https://www.bloomberg.com/company"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/hedge-funds-pile-health-stocks-103000490.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/hedge-funds-pile-health-stocks-103000490.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "REGN"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "BIIB"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-26T15:30:00+00:00",
    "headline": "Stock Split Watch: Is Eli Lilly Next?",
    "summary": "The stock recently reached beyond $1,000.",
    "url": "https://www.fool.com/investing/2025/11/26/stock-split-watch-is-eli-lilly-next/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "c7556268-497c-3bca-892c-5f38b5bc74ba",
      "content": {
        "id": "c7556268-497c-3bca-892c-5f38b5bc74ba",
        "contentType": "STORY",
        "title": "Stock Split Watch: Is Eli Lilly Next?",
        "description": "",
        "summary": "The stock recently reached beyond $1,000.",
        "pubDate": "2025-11-26T15:30:00Z",
        "displayTime": "2025-11-26T15:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/9460c1a1ed089c3e268d297295857beb",
          "originalWidth": 1200,
          "originalHeight": 800,
          "caption": "An investor works on a laptop in a living room.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9SyjPE6Vg0tvrzN8JRa.hg--~B/aD04MDA7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/9460c1a1ed089c3e268d297295857beb.cf.webp",
              "width": 1200,
              "height": 800,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xs61Bjv1.PkX82QbBIzqkQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/9460c1a1ed089c3e268d297295857beb.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/11/26/stock-split-watch-is-eli-lilly-next/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/stock-split-watch-eli-lilly-153000320.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-26T14:24:00+00:00",
    "headline": "Healthcare Equity ETF (GDOC) Hits Fresh 52-Week High",
    "summary": "GDOC hits a 52-week high as aging demographics, tech advances and strength from top holding LLY fuel momentum.",
    "url": "https://finance.yahoo.com/news/healthcare-equity-etf-gdoc-hits-142400250.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "e2e45680-22e6-3681-9a0f-0763226ad176",
      "content": {
        "id": "e2e45680-22e6-3681-9a0f-0763226ad176",
        "contentType": "STORY",
        "title": "Healthcare Equity ETF (GDOC) Hits Fresh 52-Week High",
        "description": "",
        "summary": "GDOC hits a 52-week high as aging demographics, tech advances and strength from top holding LLY fuel momentum.",
        "pubDate": "2025-11-26T14:24:00Z",
        "displayTime": "2025-11-26T14:24:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/f21818c32cbc40e4ff1ee29342da1830",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/uvPs0K8Rsd6PjzTYdz_m4A--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/f21818c32cbc40e4ff1ee29342da1830.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ClxLP_90IPzwG3UnwAEmww--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/f21818c32cbc40e4ff1ee29342da1830.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/healthcare-equity-etf-gdoc-hits-142400250.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/healthcare-equity-etf-gdoc-hits-142400250.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "GDOC"
            },
            {
              "symbol": "GS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-26T15:42:00+00:00",
    "headline": "AbbVie and Pfizer: A Closer Look at Two Pharma Heavyweights",
    "summary": "ABBV's surging immunology sales and smoother LOE path stand out as both drugmakers face a pivotal 2026.",
    "url": "https://finance.yahoo.com/news/abbvie-pfizer-closer-look-two-154200417.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "b00d3139-990c-3e0a-a401-70ed53d7a317",
      "content": {
        "id": "b00d3139-990c-3e0a-a401-70ed53d7a317",
        "contentType": "STORY",
        "title": "AbbVie and Pfizer: A Closer Look at Two Pharma Heavyweights",
        "description": "",
        "summary": "ABBV's surging immunology sales and smoother LOE path stand out as both drugmakers face a pivotal 2026.",
        "pubDate": "2025-11-26T15:42:00Z",
        "displayTime": "2025-11-26T15:42:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/00ec4a55c0f0d99f7e816f5da7894e0c",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ffSS19YaoL36xXdlr0Ip4A--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/00ec4a55c0f0d99f7e816f5da7894e0c.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/mJhhM1.2_VWzkATXxZYL_w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/00ec4a55c0f0d99f7e816f5da7894e0c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-pfizer-closer-look-two-154200417.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-pfizer-closer-look-two-154200417.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-26T16:34:00+00:00",
    "headline": "Lilly's Moment: AI-Powered Pipeline Positions Shares to Surge in 2026",
    "summary": "Eli Lilly's stock is surging amid a flurry of AI deals. Our proprietary Zacks Rank system confirms the trend.",
    "url": "https://finance.yahoo.com/news/lillys-moment-ai-powered-pipeline-163400067.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "ff2d5714-5590-3c9e-9130-f43b8a26efe0",
      "content": {
        "id": "ff2d5714-5590-3c9e-9130-f43b8a26efe0",
        "contentType": "STORY",
        "title": "Lilly's Moment: AI-Powered Pipeline Positions Shares to Surge in 2026",
        "description": "",
        "summary": "Eli Lilly's stock is surging amid a flurry of AI deals. Our proprietary Zacks Rank system confirms the trend.",
        "pubDate": "2025-11-26T16:34:00Z",
        "displayTime": "2025-11-26T16:34:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/0fdbadbb4d7e7ff0e073c7f2ff964025",
          "originalWidth": 620,
          "originalHeight": 448,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/FzTppox1p2JCDpUmeaOP.A--~B/aD00NDg7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/0fdbadbb4d7e7ff0e073c7f2ff964025.cf.webp",
              "width": 620,
              "height": 448,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/atCktd9oWMunciicjOpn1A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/0fdbadbb4d7e7ff0e073c7f2ff964025.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/lillys-moment-ai-powered-pipeline-163400067.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/lillys-moment-ai-powered-pipeline-163400067.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-26T15:45:00+00:00",
    "headline": "NVO Stock Up as Amycretin Shows Strong Weight Loss in Type 2 Diabetes",
    "summary": "Novo Nordisk jumps after phase II data show amycretin offers significant weight loss and HbA1c level reductions in type 2 diabetes patients.",
    "url": "https://finance.yahoo.com/news/nvo-stock-amycretin-shows-strong-154500320.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "f40beae8-011e-3d19-b143-894bdccabc80",
      "content": {
        "id": "f40beae8-011e-3d19-b143-894bdccabc80",
        "contentType": "STORY",
        "title": "NVO Stock Up as Amycretin Shows Strong Weight Loss in Type 2 Diabetes",
        "description": "",
        "summary": "Novo Nordisk jumps after phase II data show amycretin offers significant weight loss and HbA1c level reductions in type 2 diabetes patients.",
        "pubDate": "2025-11-26T15:45:00Z",
        "displayTime": "2025-11-26T15:45:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/59b208c03ab625710a229f805a232093",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/w5T7o1LHfvUowVKdWOi4Rg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/59b208c03ab625710a229f805a232093.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3L0ANckA9Qf5lXTiNAgdWw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/59b208c03ab625710a229f805a232093.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/nvo-stock-amycretin-shows-strong-154500320.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/nvo-stock-amycretin-shows-strong-154500320.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVO"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-26T01:52:57+00:00",
    "headline": "Trump administration slashes Medicare price for Ozempic and Wegovy",
    "summary": "The US government has negotiated a 71 per cent discount for Novo Nordisk’s weight-loss drugs Ozempic and Wegovy for patients enrolled in Medicare...",
    "url": "https://finance.yahoo.com/news/trump-administration-slashes-ozempic-wegovy-015257263.html",
    "source": "Financial Times",
    "provider": "yfinance",
    "raw": {
      "id": "40d79c9f-00e1-3ebf-a1af-7058a1562a2c",
      "content": {
        "id": "40d79c9f-00e1-3ebf-a1af-7058a1562a2c",
        "contentType": "STORY",
        "title": "Trump administration slashes Medicare price for Ozempic and Wegovy",
        "description": "",
        "summary": "The US government has negotiated a 71 per cent discount for Novo Nordisk’s weight-loss drugs Ozempic and Wegovy for patients enrolled in Medicare...",
        "pubDate": "2025-11-26T01:52:57Z",
        "displayTime": "2025-11-26T01:52:57Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2025-11/ecd6aca0-ca7d-11f0-bbdf-308e30c26b49",
          "originalWidth": 5800,
          "originalHeight": 3856,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5GN.xl0yoOZ9rASn727bRg--~B/aD0zODU2O3c9NTgwMDthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2025-11/ecd6aca0-ca7d-11f0-bbdf-308e30c26b49.cf.webp",
              "width": 5800,
              "height": 3856,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_Ur0b.rYqO.iixKcxBvlnw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2025-11/ecd6aca0-ca7d-11f0-bbdf-308e30c26b49.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Financial Times",
          "url": "https://www.ft.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/trump-administration-slashes-ozempic-wegovy-015257263.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/trump-administration-slashes-ozempic-wegovy-015257263.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVO"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]